Inventor · disambiguated record
Timothy J. Fultz
Also filed as: FULTZ TIMOTHY · FULTZ TIMOTHY J
44 granted patents·41 pending applications·5,048 citations·filing 1990–2021
99Inventor score
Files withADAMAS PHARMACEUTICALS INC42ADAMAS PHARMA LLC12WENT GREGORY T10GEN PROBE INC7MEYERSON LAURENCE R7
Top patents by PatentIndex Score
85 records- 0199US9072697B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2015·Granted Jul 7, 2015·22 cites·16 claims
- 0299US5635352ASolution phase nucleic acid sandwich assays having reduced background noiseCHIRON CORP·Filed 1995·Granted Jun 3, 1997·586 cites·25 claims
- 0399US5399491ANucleic acid sequence amplification methodsGEN PROBE INC·Filed 1992·Granted Mar 21, 1995·1.7k cites·49 claims
- 0498US10646456B2Methods of administering amantadineADAMAS PHARMA LLC·Filed 2018·Granted May 12, 2020·34 cites·58 claims
- 0598US8987333B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Mar 24, 2015·20 cites·11 claims
- 0698US8895617B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·17 claims
- 0798US8895618B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·12 claims
- 0898US8895616B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·14 claims
- 0998US8895615B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·16 claims
- 1098US8895614B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·11 claims
- 1198US8889740B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 18, 2014·21 cites·9 claims
- 1298US8796337B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·27 cites·14 claims
- 1398US8389578B2Composition and method for treating neurological diseaseWENT GREGORY T·Filed 2005·Granted Mar 5, 2013·94 cites·8 claims
- 1498US8058291B2Methods and compositions for the treatment of CNS-related conditionsWENT GREGORY T·Filed 2006·Granted Nov 15, 2011·47 cites·58 claims
- 1598US7619007B2Method and composition for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2005·Granted Nov 17, 2009·53 cites·20 claims
- 1698US5681697ASolution phase nucleic acid sandwich assays having reduced background noise and kits thereforCHIRON CORP·Filed 1993·Granted Oct 28, 1997·297 cites·8 claims
- 1797US8580858B2Compositions for the treatment of CNS-related conditionsADAMAS PHARMACEUTICALS INC·Filed 2012·Granted Nov 12, 2013·22 cites·10 claims
- 1897US8426472B2Method and composition for administering an NMDA receptor antagonist to a subjectWENT GREGORY T·Filed 2011·Granted Apr 23, 2013·20 cites·10 claims
- 1997US8362085B2Method for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2012·Granted Jan 29, 2013·33 cites·12 claims
- 2097US8338486B2Methods for the treatment of CNS-related conditionsWENT GREGORY T·Filed 2012·Granted Dec 25, 2012·24 cites·12 claims
- 2197US8338485B2Compositions for the treatment of CNS-related conditionsWENT GREGORY T·Filed 2012·Granted Dec 25, 2012·23 cites·16 claims
- 2297US8293794B2Methods and compositions for the treatment of CNS-related conditionsWENT GREGORY T·Filed 2010·Granted Oct 23, 2012·24 cites·28 claims
- 2397US8283379B2Methods and compositions for the treatment of CNS-related conditionsWENT GREGORY T·Filed 2010·Granted Oct 9, 2012·33 cites·15 claims
- 2497US8168209B2Method and composition for administering an NMDA receptor antagonist to a subjectWENT GREGORY T·Filed 2009·Granted May 1, 2012·35 cites·15 claims
- 2597US5849481ANucleic acid hybridization assays employing large comb-type branched polynucleotidesCHIRON CORP·Filed 1995·Granted Dec 15, 1998·417 cites·6 claims
- 2697US5824518ANucleic acid sequence amplification methodsGEN PROBE INC·Filed 1995·Granted Oct 20, 1998·313 cites·14 claims
- 2796US8598233B2Method for administering an NMDA receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2013·Granted Dec 3, 2013·21 cites·18 claims
- 2896US8329752B2Composition for administering an NMDA receptor antagonist to a subjectWENT GREGORY T·Filed 2012·Granted Dec 11, 2012·24 cites·16 claims
- 2996US8173708B2Method and composition for administering an NMDA receptor antagonist to a subjectWENT GREGORY T·Filed 2010·Granted May 8, 2012·24 cites·18 claims
- 3095US5710264ALarge comb type branched polynucleotidesCHIRON CORP·Filed 1995·Granted Jan 20, 1998·213 cites·36 claims
- 3195US5480784ANucleic acid sequence amplification methodsGEN PROBE INC·Filed 1990·Granted Jan 2, 1996·436 cites·6 claims
- 3294US5888779AKits for nucleic acid sequence amplification methodsGEN PROBE INC·Filed 1995·Granted Mar 30, 1999·229 cites·16 claims
- 3392US10154971B2Methods of administering amantadineADAMAS PHARMA LLC·Filed 2014·Granted Dec 18, 2018·8 cites·56 claims
- 3492US7981930B2Compositions and kits for treating influenzaADAMAS PHARMACEUTICALS INC·Filed 2008·Granted Jul 19, 2011·22 cites·7 claims
- 3592US7858660B2Compositions and kits for treating influenzaADAMAS PHARMACEUTICALS INC·Filed 2009·Granted Dec 28, 2010·20 cites·44 claims
- 3688US10987324B2Methods and compositions for the treatment of seizure-related disordersADAMAS PHARMACEUTICALS INC·Filed 2018·Granted Apr 27, 2021·3 cites·18 claims
- 3787US11077073B2Methods of using amantadine compositionsADAMAS PHARMA LLC·Filed 2019·Granted Aug 3, 2021·2 cites·11 claims
- 3887US11065213B2Amantadine compositions and preparations thereofADAMAS PHARMA LLC·Filed 2019·Granted Jul 20, 2021·2 cites·9 claims
- 3986US11903908B2Methods of administering amantadineADAMAS PHARMA LLC·Filed 2020·Granted Feb 20, 2024·1 cites·46 claims
- 4080US10973783B2Methods and compositions for the treatment of seizure-related disordersADAMAS PHARMACEUTICALS INC·Filed 2016·Granted Apr 13, 2021·1 cites·34 claims
- 4180US7083922B2Detection of HIVGEN PROBE INC·Filed 2002·Granted Aug 1, 2006·5 cites·80 claims
- 4274US2014135529A1Method for administering an nmda receptor antagonist to a subjectADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4373US2017151189A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4473US2017151188A1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4572US2010022659A1Methods and Compositions for the Treatment of CNS-Related ConditionsMEYERSON LAURENCE R·Filed 2009·Application pending·0 cites
- 4672US2013165517A1Composition and Method for Treating Neurological DiseaseADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4771US12233033B2Amantadine compositions, preparations thereof, and methods of useADAMAS PHARMA LLC·Filed 2021·Granted Feb 25, 2025·0 cites·34 claims
- 4871US2010029665A1Methods and Compositions for Treating Migraine PainMEYERSON LAURENCE R·Filed 2009·Application pending·0 cites
- 4971US2017281565A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMA LLC·Filed 2016·Application pending·0 cites
- 5070US2018263914A1Compositions for the treatment of cns-related conditionsADAMAS PHARMA LLC·Filed 2017·Application pending·0 cites
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Timothy J. Fultz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →